Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples